News
Shares of Carisma Therapeutics Inc. (CARM) have been struggling lately and have lost 12.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could ...
Carisma Therapeutics Inc. (CARM) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
The current price CARISMA Therapeutics (CARM) is trading at is $0.20, which is out of the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. People Also Watch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results